Table 2. Cost and utility values.

Parameter	Value	Range		Distribution	Source
		Lower	Upper
Cycle cost ($)
Empagliflozin	28.42	8.50	83.58	Gamma	Menet
Standard treatment	110.55	88.44	132.66	Gamma	Huang et al. (2)
HF hospitalization	2,016.51	1,613.21	2,419.81	Gamma	Huang et al. (2)
HF readmission	1,407.05	1,125.64	1,688.46	Gamma	Huang et al. (2)
Utility
NYHA II	0.780	0.741	0.819	Beta	Xuan et al. (16)
NYHA III	0.715	0.679	0.751	Beta	Xuan et al. (16)
NYHA IV	0.660	0.627	0.693	Beta	Xuan et al. (16)
Disutility
Hospitalization/readmission	–0.1	–0.13	–0.08	Beta	King et al. (9), Yao et al. (17)

HF, heart failure; NYHA, New York Heart Association.